• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 与神经认知功能障碍:药物治疗的新分子靶点?

MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?

机构信息

Centre de Biophysique Moleculaire, CNRS UPR4301, Universite d'Orleans France, 45071 Orleans Cedex, France.

出版信息

Curr Neuropharmacol. 2017;15(2):260-275. doi: 10.2174/1570159x14666160709001441.

DOI:10.2174/1570159x14666160709001441
PMID:27396304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5412695/
Abstract

BACKGROUND

Neurodegenerative and cognitive disorders are multifactorial diseases (i.e., involving neurodevelopmental, genetic, age or environmental factors) characterized by an abnormal development that affects neuronal function and integrity. Recently, an increasing number of studies revealed that the dysregulation of microRNAs (miRNAs) may be involved in the etiology of cognitive disorders as Alzheimer, Parkinson, and Huntington's diseases, Schizophrenia and Autism spectrum disorders.

METHODS

From an extensive search in bibliographic databases of peer-reviewed research literature, we identified relevant published studies related to specific key words such as memory, cognition, neurodegenerative disorders, neurogenesis and miRNA. We then analysed, evaluated and summerized scientific evidences derived from these studies.

RESULTS

We first briefly summarize the basic molecular events involved in memory, a process inherent to cognitive disease, and then describe the role of miRNAs in neurodevelopment, synaptic plasticity and memory. Secondly, we provide an overview of the impact of miRNA dysregulation in the pathogenesis of different neurocognitive disorders, and lastly discuss the feasibility of miRNA-based therapeutics in the treatment of these disorders.

CONCLUSION

This review highlights the molecular basis of neurodegenerative and cognitive disorders by focusing on the impact of miRNAs dysregulation in these pathological phenotypes. Altogether, the published reports suggest that miRNAs-based therapy could be a viable therapeutic alternative to current treatment options in the future.

摘要

背景

神经退行性和认知障碍是多因素疾病(即涉及神经发育、遗传、年龄或环境因素),其特征是异常发育,影响神经元功能和完整性。最近,越来越多的研究表明,microRNAs(miRNAs)的失调可能与认知障碍的病因有关,如阿尔茨海默病、帕金森病和亨廷顿病、精神分裂症和自闭症谱系障碍。

方法

我们从同行评议的研究文献的广泛文献数据库中进行了搜索,确定了与特定关键词(如记忆、认知、神经退行性疾病、神经发生和 miRNA)相关的已发表研究。然后,我们分析、评估和总结了这些研究得出的科学证据。

结果

我们首先简要总结了记忆过程中涉及的基本分子事件,记忆是认知疾病固有的过程,然后描述了 miRNAs 在神经发育、突触可塑性和记忆中的作用。其次,我们概述了 miRNA 失调对不同神经认知障碍发病机制的影响,最后讨论了 miRNA 为基础的治疗在治疗这些障碍中的可行性。

结论

本综述通过关注 miRNA 失调对这些病理表型的影响,强调了神经退行性和认知障碍的分子基础。总之,已发表的报告表明,基于 miRNAs 的治疗可能是未来替代当前治疗选择的可行治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1774/5412695/caf7f0629649/CN-15-260_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1774/5412695/caf7f0629649/CN-15-260_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1774/5412695/caf7f0629649/CN-15-260_F1.jpg

相似文献

1
MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?微小 RNA 与神经认知功能障碍:药物治疗的新分子靶点?
Curr Neuropharmacol. 2017;15(2):260-275. doi: 10.2174/1570159x14666160709001441.
2
Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities.神经认知疾病中 microRNA 表达的药物调节:障碍与未来机遇。
Curr Neuropharmacol. 2017;15(2):276-290. doi: 10.2174/1570159x14666160630210422.
3
miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.微小RNA:神经退行性疾病和癫痫中的关键因素
J Alzheimers Dis. 2015;48(3):563-80. doi: 10.3233/JAD-150395.
4
Micro-RNAs in cognition and cognitive disorders: Potential for novel biomarkers and therapeutics.认知与认知障碍中的微小RNA:新型生物标志物及治疗方法的潜力
Biochem Pharmacol. 2016 Mar 15;104:1-7. doi: 10.1016/j.bcp.2015.11.021. Epub 2015 Nov 25.
5
MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.神经精神疾病和认知功能障碍中的 microRNA 失调。
Neurobiol Dis. 2012 May;46(2):291-301. doi: 10.1016/j.nbd.2012.02.016. Epub 2012 Mar 3.
6
microRNAs and Neurodegenerative Diseases.微小RNA与神经退行性疾病
Adv Exp Med Biol. 2015;888:85-105. doi: 10.1007/978-3-319-22671-2_6.
7
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.靶向微小RNA用于神经退行性疾病的预防和治疗。
Drug Dev Res. 2015 Nov;76(7):397-418. doi: 10.1002/ddr.21277. Epub 2015 Sep 11.
8
MicroRNAs in non-small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential.非小细胞肺癌中的 microRNAs:基因调控、对癌症细胞过程的影响及治疗潜力。
Pharmacol Res Perspect. 2019 Dec;7(6):e00528. doi: 10.1002/prp2.528.
9
Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.利用 miRNA 抑制剂的纳米治疗方法靶向治疗呼吸疾病:现状与未来展望。
Nanomedicine. 2021 Jan;31:102303. doi: 10.1016/j.nano.2020.102303. Epub 2020 Sep 24.
10
Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.miRNAs 在神经退行性变中的作用:从疾病原因到生物标志物发现和治疗工具。
Genes (Basel). 2022 Feb 25;13(3):425. doi: 10.3390/genes13030425.

引用本文的文献

1
Potential biofluid markers for cognitive impairment in Parkinson's disease.帕金森病认知障碍的潜在生物流体标志物。
Neural Regen Res. 2024 Dec 7;21(1):281-95. doi: 10.4103/NRR.NRR-D-24-00592.
2
From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach.从理解到行动:探索唐氏综合征与阿尔茨海默病的分子联系以制定靶向治疗方法。
Alzheimers Dement (Amst). 2024 Apr 14;16(2):e12580. doi: 10.1002/dad2.12580. eCollection 2024 Apr-Jun.
3
Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease.

本文引用的文献

1
MiR-980 Is a Memory Suppressor MicroRNA that Regulates the Autism-Susceptibility Gene A2bp1.miR-980 是一种记忆抑制 microRNA,可调节自闭症易感基因 A2bp1。
Cell Rep. 2016 Feb 23;14(7):1698-1709. doi: 10.1016/j.celrep.2016.01.040. Epub 2016 Feb 11.
2
MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells.miR-634 通过靶向调控 mTOR 信号通路抑制宫颈癌 Hela 细胞增殖并诱导其凋亡。
Artif Cells Nanomed Biotechnol. 2016 Nov;44(7):1694-701. doi: 10.3109/21691401.2015.1080171. Epub 2015 Sep 14.
3
miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
血浆 miR-203a-3p 作为帕金森病患者痴呆的新型预测因子。
Int J Mol Sci. 2024 Mar 21;25(6):3554. doi: 10.3390/ijms25063554.
4
APPlications of amyloid-β precursor protein metabolites in macrocephaly and autism spectrum disorder.淀粉样前体蛋白代谢产物在巨头症和自闭症谱系障碍中的应用。
Front Mol Neurosci. 2023 Sep 20;16:1201744. doi: 10.3389/fnmol.2023.1201744. eCollection 2023.
5
Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior.循环 miRNA 作为心境障碍及相关自杀行为分子标志物的潜力。
Int J Mol Sci. 2023 Feb 28;24(5):4664. doi: 10.3390/ijms24054664.
6
Mapping miRNA Research in Schizophrenia: A Scientometric Review.精神分裂症 miRNA 研究的绘制:一项科学计量学综述。
Int J Mol Sci. 2022 Dec 27;24(1):436. doi: 10.3390/ijms24010436.
7
miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease.基于微小RNA和反义寡核苷酸的α-突触核蛋白靶向治疗作为帕金森病的疾病修饰疗法
Front Pharmacol. 2022 Nov 15;13:1034072. doi: 10.3389/fphar.2022.1034072. eCollection 2022.
8
Mahonia Alkaloids (MA) Ameliorate Depression Induced Gap Junction Dysfunction by miR-205/Cx43 Axis.黄连生物碱(MA)通过 miR-205/Cx43 轴改善抑郁诱导的缝隙连接功能障碍。
Neurochem Res. 2022 Dec;47(12):3761-3776. doi: 10.1007/s11064-022-03761-3. Epub 2022 Oct 12.
9
MicroRNA silencing: A promising therapy for Alzheimer's disease.微小RNA沉默:一种治疗阿尔茨海默病的有前景的疗法。
Neurosci Chron. 2020;1(1):11-15. doi: 10.46439/neuroscience.1.004.
10
Preeclampsia, Natural History, Genes, and miRNAs Associated with the Syndrome.子痫前期的自然史、基因与 miRNA 及其与该综合征的关系。
J Pregnancy. 2022 Feb 14;2022:3851225. doi: 10.1155/2022/3851225. eCollection 2022.
微小RNA-199a将甲基化CpG结合蛋白2与雷帕霉素靶蛋白信号通路联系起来,其失调会导致雷特综合征表型。
Cell Rep. 2015 Sep 22;12(11):1887-901. doi: 10.1016/j.celrep.2015.08.028. Epub 2015 Sep 3.
4
miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.微小RNA-99b-5p通过下调雷帕霉素靶蛋白(mTOR)抑制结直肠癌肝转移。
Oncotarget. 2015 Sep 15;6(27):24448-62. doi: 10.18632/oncotarget.4423.
5
Cellular and molecular introduction to brain development.大脑发育的细胞与分子导论。
Neurobiol Dis. 2016 Aug;92(Pt A):3-17. doi: 10.1016/j.nbd.2015.07.007. Epub 2015 Jul 13.
6
Differential effects of social and physical environmental enrichment on brain plasticity, cognition, and ultrasonic communication in rats.社交和物理环境丰富化对大鼠大脑可塑性、认知及超声通讯的不同影响。
J Comp Neurol. 2016 Jun 1;524(8):1586-607. doi: 10.1002/cne.23842. Epub 2015 Aug 10.
7
microRNAs That Promote or Inhibit Memory Formation in Drosophila melanogaster.促进或抑制黑腹果蝇记忆形成的微小RNA
Genetics. 2015 Jun;200(2):569-80. doi: 10.1534/genetics.114.169623.
8
MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.脑脊液的微小RNA分析揭示了检测阿尔茨海默病的潜在生物标志物。
PLoS One. 2015 May 20;10(5):e0126423. doi: 10.1371/journal.pone.0126423. eCollection 2015.
9
Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.精神分裂症患者大脑皮层第3层锥体细胞中CDC42信号通路成分的表达改变。
Biol Psychiatry. 2015 Dec 1;78(11):775-85. doi: 10.1016/j.biopsych.2015.03.030. Epub 2015 Apr 11.
10
miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.亨廷顿舞蹈症患者大脑中miR-10b-5p的表达与发病年龄及纹状体受累程度相关。
BMC Med Genomics. 2015 Mar 1;8:10. doi: 10.1186/s12920-015-0083-3.